Health Elevar Therapeutics Announces FDA Acceptance for Filing of New Drug Application for Rivoceranib in… James Pereira Jul 17, 2023 FORT LEE, N.J., July 17, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co.,… Read More...
Health HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of… James Pereira Mar 31, 2023 <!-- Name:DistributionId Value:8799000 --> <!--… Read More...
Entertainment Reports: Tiger Woods’ apparent ex-girlfriend wants to void NDA Eli Pacheco Mar 9, 2023 Field Level Media Tiger Woods and longtime girlfriend Erica Herman appear to have… Read More...
Sports Tiger Woods’ ex-girlfriend asks judge to nullify NDA Amelia Podder Mar 9, 2023 Tiger Woods speaks to the media during a press conference prior to the 2018 PGA Championship at Bellerive… Read More...
Health Junshi Biosciences Announces Acceptance of NDA for VV116 in China James Pereira Jan 18, 2023 SHANGHAI, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX:… Read More...
Health Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the… James Pereira Jan 7, 2023 – Potential FDA approval anticipated in first quarter 2024, assuming the filing is accepted by the FDA and under… Read More...
Health Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the… James Pereira Dec 28, 2022 BURLINGTON, Mass., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage… Read More...
Health HUTCHMED Initiates Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of… James Pereira Dec 19, 2022 — Company plans to complete rolling submission to the U.S. in the first half of 2023, followed by filings in Europe and… Read More...
Technology Here’s why Elon Musk is threatening to sue employees at Twitter – Times of India Kevin Colleran Dec 12, 2022 Elon Muskhas reportedly warned employees at Twitter that the company will sue those who leak confidential information… Read More...
Health Ark Biopharmaceutical Announces NMPA Acceptance and Priority Review of New Drug Application for… James Pereira Dec 9, 2022 SHANGHAI, China, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Shanghai Ark Biopharmaceutical Co., Ltd. (Ark Biopharmaceutical),… Read More...